Dr. Harald Stover, a chemistry professor at McMaster University and co-founder of the Hamilton-based company, Allarta Life Science, is behind breakthrough research that aims to cure diabetes with a cell-based therapy, in which new curative cells transplanted into the body do the work to produce insulin — alleviating the need for injections and immune-suppressive drugs.
In a recent interview with The Hamilton Spectator, Allarta founders, Dr. Harald Stover and Maria Antonakos, talk about their work that has the potential to change the scenario of diabetes around the world.
Allarta is a past CAAP® participant and presented at the OBIO Investment Summit.